Price $0.75 |
Market Cap
127.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
0.97
|
P/S
3.22
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-118.1K
|
FCF
-0.8
|
|
Op. Margin
-270.50%
|
Net Margin
-267.60%
|
ROE
-62.20%
|
ROI
-51.50%
|
|
ROA
-46.80%
|
EPS Growth
-9.20%
|
Current Ratio
5.7
|
Debt/Equity
7.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Omeros Corporation (OMER) | $7.05 | - | - | 457.4M | Strong Buy |
| Jazz Pharmaceuticals PLC (JAZZ) | $128.52 | - | - | 8.26B | Strong Buy |
| Aytu Biopharma Inc (AYTU) | $1.60 | - | - | 6.5M | Strong Buy |
| Akumin Inc (AKU) | $0.40 | - | - | 35.7M | Strong Buy |
| Item 9 Labs Corp (INLB) | $0.09 | - | - | 7.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
